BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 6276922)

  • 1. [Mechanisms of action of and resistance to colistinpolymyxin group antibiotics including resistance of colitin-producing bacterium, Bacillus colistinus to colistin (author's transl)].
    Shirai M; Aida T
    Tanpakushitsu Kakusan Koso; 1981 Nov; 26(14):2070-83. PubMed ID: 6276922
    [No Abstract]   [Full Text] [Related]  

  • 2. [Resistance in vitro of Psudomonas aeruginosa to gentamicin compared with colistin and polymyxin B].
    Bergan T
    Nord Med; 1969 Jan; 81(3):73-5. PubMed ID: 4304204
    [No Abstract]   [Full Text] [Related]  

  • 3. [Polymyxin salt of phenoxymethylpenicillin].
    Bishara EI; Lazareva EN; Potravnova RS
    Antibiotiki; 1966 Jan; 11(1):10-4. PubMed ID: 4291641
    [No Abstract]   [Full Text] [Related]  

  • 4. Synergistic action of polysorbate 80 and polymyxin B sulphate on Pseudomonas aeruginosa.
    Brown MR; Winsley BE
    J Gen Microbiol; 1968 Mar; 50(3):Suppl:ix. PubMed ID: 4297318
    [No Abstract]   [Full Text] [Related]  

  • 5. Electron microscopic studies on mode of action of polymyxin.
    Koike M; Iida K; Matsuo T
    J Bacteriol; 1969 Jan; 97(1):448-52. PubMed ID: 4303542
    [No Abstract]   [Full Text] [Related]  

  • 6. [Bisodic alpha-carboxybenzyl-penicillin (carbenicillin): antimicrobial activity on strains of Pseudomonas aeruginosa].
    Notarrigo A; Patti AM
    Ann Ist Super Sanita; 1974; 10(1-2):26-34. PubMed ID: 4377387
    [No Abstract]   [Full Text] [Related]  

  • 7. Polymyxins: older antibiotics for a new threat.
    Lee SY; Kuti JL; Nicolau DP
    Conn Med; 2006 Jan; 70(1):25-8. PubMed ID: 16479873
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Studies on the mechanism of action of colistin. II. Alteration of permeability of Escherichia coli by colistin.
    Nakajima K; Kawamata J
    Biken J; 1965 Dec; 8(4):233-9. PubMed ID: 5325231
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of the nutritional environment on the development of resistance to polymyxin B in Pseudomonas aeruginosa and its prevention by atabrine.
    DeCourcy SJ; Mudd S
    Antimicrob Agents Chemother (Bethesda); 1968; 8():72-7. PubMed ID: 4309853
    [No Abstract]   [Full Text] [Related]  

  • 10. [In vitro sensitivity of Pseudomonas aeruginosa to gentamicin].
    Cocchi P; Panero C
    Minerva Med; 1967 Nov; 58(95 Suppl):4191-3. PubMed ID: 4295503
    [No Abstract]   [Full Text] [Related]  

  • 11. On the problem of efficient antibiotic therapy of infections caused by Pseudomonas aeruginosa.
    Vacek V; Wagnerová M
    Chemotherapy; 1969; 14(5):308-21. PubMed ID: 4311865
    [No Abstract]   [Full Text] [Related]  

  • 12. Synergism between chlorhexidine and polymyxins against Pseudomonas aeruginosa.
    Al-Najjar AR; Quesnel LB
    J Appl Bacteriol; 1979 Dec; 47(3):469-76. PubMed ID: 232100
    [No Abstract]   [Full Text] [Related]  

  • 13. Pitfalls of polymyxin antimicrobial susceptibility testing of Pseudomonas aeruginosa isolated from cystic fibrosis patients.
    Hogardt M; Schmoldt S; Götzfried M; Adler K; Heesemann J
    J Antimicrob Chemother; 2004 Dec; 54(6):1057-61. PubMed ID: 15509615
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effect of polymyxins on Bacillus polymyxa sporogenesis].
    Nefelova NV; Filippova MS; Egorov NS
    Mikrobiologiia; 1980; 49(2):294-7. PubMed ID: 6248743
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ultrastructural changes produced in Proteus vulgaris by a synergistic combination of colistin and sulphadiazine.
    Handley PS; Quesnel LB; Sturgiss MM
    Microbios; 1974 May; 10(40):211-23. PubMed ID: 4369409
    [No Abstract]   [Full Text] [Related]  

  • 16. Colistin: the revival of polymyxins for the management of multidrug-resistant gram-negative bacterial infections.
    Falagas ME; Kasiakou SK
    Clin Infect Dis; 2005 May; 40(9):1333-41. PubMed ID: 15825037
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activity of colistin against Pseudomonas aeruginosa: inhibition by calcium.
    Davis SD; Iannetta A; Wedgwood RJ
    J Infect Dis; 1971 Dec; 124(6):610-2. PubMed ID: 4331350
    [No Abstract]   [Full Text] [Related]  

  • 18. Efficacy and safety of colistin (colistimethate sodium) for therapy of infections caused by multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii in Siriraj Hospital, Bangkok, Thailand.
    Koomanachai P; Tiengrim S; Kiratisin P; Thamlikitkul V
    Int J Infect Dis; 2007 Sep; 11(5):402-6. PubMed ID: 17291803
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cationic antibiotics and phospholipase C as tools in the study of phospholipid structure and function. I. Inhibition of the in vitro clotting system by cationic antibiotics.
    Ottolenghi AC
    Can J Biochem; 1967 Feb; 45(2):239-44. PubMed ID: 4290011
    [No Abstract]   [Full Text] [Related]  

  • 20. Colistin: an antimicrobial for the 21st century?
    Stein A; Raoult D
    Clin Infect Dis; 2002 Oct; 35(7):901-2. PubMed ID: 12228836
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.